New therapeutic options for chronic wounds

Dermatologic Clinics

Volumn 20, Issue 2, 2002, Pages 357-363

  Límová, Markéta ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; BASIC FIBROBLAST GROWTH FACTOR; BECAPLERMIN; COLLAGEN TYPE 4; COLLAGEN TYPE 7; CYTOKINE; FIBRONECTIN; GLYCOSAMINOGLYCAN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; KALININ; LAMININ; NERVE GROWTH FACTOR; PLASMINOGEN ACTIVATOR; PLATELET DERIVED GROWTH FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SCLEROPROTEIN; THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

AUTOGRAFT; BIOENGINEERING; CELL CULTURE; CLINICAL RESEARCH; HUMAN; PRIORITY JOURNAL; REVIEW; WOUND; WOUND HEALING; CHRONIC DISEASE; DIABETIC FOOT; INJURY; METHODOLOGY; SKIN; SKIN TRANSPLANTATION; SKIN ULCER;

CHRONIC DISEASE; DIABETIC FOOT; HUMAN; SKIN; SKIN TRANSPLANTATION; SKIN ULCER; WOUND HEALING; HUMANS;

EID: 0036085563     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(01)00030-4     Document Type: Review

References (18)

1. Management of chronic venous ulcers: A literature-guided approach
2. Wound healing
3. Synthetic membranes and cultured keratinocyte grafts
4. Efficacy and safety of topical gel formulation of recombinant human plateletderived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers
5. Role of platelet-derived growth factor as an adjunct to surgery in the management of pressure ulcers
6. Randomized, double-blind, placebo-controlled, dose-ranging study of granulocyte-macrophage colony stimulating factor in patients with chronic venous leg ulcers
7. Recombinant human GM-CSF in the treatment of poorly healing wounds
8. Keratinocyte growth factor-2: A wound healing agent with epidermal and dermal activity
9. (rhuKGF-2) as a human wound healing agent
10. Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells
11. Permanent coverage of large burn wounds with autologous cultured human epithelium
12. Treatment of chronic venous ulcers with sheets of cultured allogenic keratinocytes
13. Treatment of leg ulcers with cultured epithelial autografts: Treatment protocol and five year experience
14. Skin regenerated from cultured epithelial autografts on full-thickness bum wounds from 6 days to 5 years after grafting: A light, electron microscopic and immunohistochemical study
15. Burn wound closure with cultured autologous keratinocytes and fibroblasts attached to a collagen-glycosaminoglycan substrate
16. The role of Apligraf in the treatment of venous leg ulcers
17. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent
18. The use of tissue-engineered skin (Apligraf) to treat a newborn with epidermolysis bullosa